Integrative transcriptomics and network analysis reveals core genes driving meningioma pathogenesis and clinical outcomes
RNA-seq (gene expression) · human · 40 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 40 samples: 14 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Integrative transcriptomics and network analysis reveals core genes driving meningioma pathogenesis and clinical outcomesScientific reports · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE285889_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1206713 and SRA study SRP555367. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 40 samples.
How we read this: 14 replicated groups read from 40 sample titles; they account for 40 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8712034 D1-1 D1
- GSM8712035 D1-2 D1
- GSM8712036 D2-1 D2
- GSM8712037 D2-2 D2
- GSM8712038 D2-3 D2
- GSM8712039 D3-1 D3
- GSM8712040 D3-2 D3
- GSM8712041 P2-1 P2
- GSM8712042 P2-2 P2
- GSM8712043 P2-3 P2
- GSM8712044 P3-1 P3
- GSM8712045 P3-2 P3
- GSM8712046 P3-3 P3
- GSM8712047 P4-1 P4
- GSM8712048 P4-2 P4
- GSM8712049 P4-3 P4
- GSM8712050 P5A-1 P5A
- GSM8712051 P5A-2 P5A
- GSM8712052 P5A-3 P5A
- GSM8712053 P5B-1 P5B
- GSM8712054 P5B-2 P5B
- GSM8712055 P5B-3 P5B
- GSM8712056 P6-1 P6
- GSM8712057 P6-2 P6
- GSM8712058 P6-3 P6
- GSM8712059 P7-1 P7
- GSM8712060 P7-2 P7
- GSM8712061 P7-3 P7
- GSM8712062 P8-1 P8
- GSM8712063 P8-2 P8
- GSM8712064 P8-3 P8
- GSM8712065 P9-1 P9
- GSM8712066 P9-2 P9
- GSM8712067 P9-3 P9
- GSM8712068 P10A-1 P10A
- GSM8712069 P10A-2 P10A
- GSM8712070 P10A-3 P10A
- GSM8712071 P10B-1 P10B
- GSM8712072 P10B-2 P10B
- GSM8712073 P10B-3 P10B
- GSE297413 Genomic and transcriptomic determinants of clinical outcomes in patients with AML and DNMT3A mutations 264 samples shares clinical, outcomes
- GSE318816 Blood-based Molecular Endotyping of Fibrotic Hypersensitivity Pneumonitis Identifies Two Immune Subtypes with Divergent Clinical Outcomes 126 samples shares clinical, outcomes
- GSE326320 Integrative transcriptomic, network, and genomic analysis of peripheral blood mononuclear cells identifies candidate gene drivers of dupilumab clinical response in atopic dermatitis patients 36 samples shares clinical, network
- GSE253769 Autophagy-enhancing ATG16L1 polymorphism improves clinical outcomes and promotes superior T-cell immunity in chronic HIV-1 infection 32 samples shares clinical, outcomes
- GSE282752 Clinical evaluation of a functional combinatorial precision medicine platform to predict treatment outcomes and enhance combination therapy design in soft tissue sarcomas 24 samples shares clinical, outcomes
- GSE264695 Neoadjuvant anti-PD1 immunotherapy for surgically accessible recurrent glioblastoma: clinical and molecular outcomes of a stage 2 single-arm expansion cohort 20 samples shares clinical, outcomes
- GSE62254 Molecular analysis of gastric cancer identifies discrete subtypes associated with distinct clinical characteristics and survival outcomes: the ACRG (Asian Cancer Research Group) study [gastric tumors] 300 samples shares clinical, outcomes
- GSE280063 Clinical and Immunological Outcomes after Randomized Trial of Baked Milk Oral Immunotherapy for Milk Allergy 24 samples shares clinical, outcomes
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.